Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.

Abstract

Existing ILD adversely affects the outcome of NSCLC. When deciding whether or not to offer a standard therapy which may increase treatment-related mortality, the patient's medical condition, including ILD, should be taken into consideration.